Series B - Alebund Pharmaceuticals - May 9, 2021 Funding Round Profile - Cointime

Bitcoin $94,701.73 -2.93%
Ethereum $3,447.07 +3.14%
BNB $644.00 -1.82%
Optimism $2.29 +6.84%
Arbitrum $0.91 +8.13%
Solana $237.81 -5.01%
Polygon $0.56 +1.47%
Cosmos $8.05 -3.93%
Avalanche $42.75 +4.02%

Bitcoin $94,701.73 -2.93%
Ethereum $3,447.07 +3.14%
BNB $644.00 -1.82%
Optimism $2.29 +6.84%
Arbitrum $0.91 +8.13%
Solana $237.81 -5.01%
Polygon $0.56 +1.47%
Cosmos $8.05 -3.93%
Avalanche $42.75 +4.02%

Alebund Pharmaceuticals

company

Funding Round

Series B

Money Raised

$ 60M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Lilly Asia Ventures	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Jan 1, 2020	Series A	0	Lilly Asia Ventures	Detail